TSMM 0719

Welcome to the inaugural issue of The Small Molecule Manufacturer! In Upfront, we examine key statistics that highlight just how big the market is for small molecule drugs, as well as why continuous wet granulation was chosen for a UK project involving GSK, AstraZeneca and CPI. For our cover feature, we look at a staple manufacturing technique: tabletting, including best practices on maintaining equipment and how industry trends are affecting innovation in tablet presses and tooling. Also included in the issue is dry granulation, 3D inkjet printing, and a special interview with Brian Henry from the Pharmaceutical Sciences Department at Pfizer.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online